Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Insys Theraptcs (INSY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 321,529
  • Shares Outstanding, K 74,428
  • Annual Sales, $ 82,080 K
  • Annual Income, $ -124,510 K
  • 60-Month Beta 2.51
  • Price/Sales 3.82
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +454,190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +11.50%
on 04/15/19
4.97 -10.26%
on 04/09/19
+0.05 (+1.13%)
since 03/22/19
3-Month
3.38 +31.95%
on 02/01/19
6.71 -33.53%
on 03/04/19
+0.44 (+10.95%)
since 01/23/19
52-Week
3.35 +33.13%
on 12/28/18
11.65 -61.72%
on 08/30/18
-2.58 (-36.65%)
since 04/23/18

Most Recent Stories

More News
INSYS Therapeutics Implements Leadership Changes

INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that the Board of Directors...

INSY : 4.46 (+3.24%)
Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutics, and OMNOVA Solutions -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Zscaler, Inc. (NASDAQ:ZS), Golden...

OMN : 7.50 (+1.08%)
GSS : 4.00 (-0.74%)
ZS : 65.42 (+1.81%)
INSY : 4.46 (+3.24%)
GLNS : 0.9000 (-14.08%)
FLXN : 10.74 (+4.99%)
SP : 34.82 (+0.99%)
Implied Volatility Surging for INSYS Therapeutics (INSY) Stock Options

Investors need to pay close attention to INSYS Therapeutics (INSY) stock based on the movements in the options market lately.

INSY : 4.46 (+3.24%)
Insys Therapeutics (INSY) Outpaces Stock Market Gains: What You Should Know

Insys Therapeutics (INSY) closed the most recent trading day at $4.62, moving +1.99% from the previous trading session.

INSY : 4.46 (+3.24%)
INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting

INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the Company will present a poster...

INSY : 4.46 (+3.24%)
Insys Therapeutics (INSY) Outpaces Stock Market Gains: What You Should Know

Insys Therapeutics (INSY) closed at $4.81 in the latest trading session, marking a +1.69% move from the prior day.

INSY : 4.46 (+3.24%)
Insys Plunges on Auditor's Concern About Insufficient Funds

Insys Therapeutics' (INSY) shares plunge after its auditor raises concerns related to insufficiency of funds to continue operations.

MYL : 26.60 (-0.45%)
ENDP : 7.38 (+3.22%)
INSY : 4.46 (+3.24%)
TEVA : 14.91 (+1.43%)
13.2% Return Seen to Date on SmarTrend Insys Therapeuti Call (INSY)

SmarTrend identified an Uptrend for Insys Therapeuti (NASDAQ:INSY) on February 12th, 2019 at $4.56. In approximately 3 weeks, Insys Therapeuti has returned 13.16% as of today's recent price of $5.16.

INSY : 4.46 (+3.24%)
INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results

INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported financial results for its fourth...

INSY : 4.46 (+3.24%)
INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that it will release its fourth...

INSY : 4.46 (+3.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade INSY with:

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Key Turning Points

2nd Resistance Point 4.75
1st Resistance Point 4.61
Last Price 4.46
1st Support Level 4.27
2nd Support Level 4.07

See More

52-Week High 11.65
Fibonacci 61.8% 8.48
Fibonacci 50% 7.50
Fibonacci 38.2% 6.52
Last Price 4.46
52-Week Low 3.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar